2 completed, 1 unknown, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Phase 1 | 1 | Unknown 1 |
Follow nepicastat: new trials by email Literature Review of nepicastat trials Research Report on nepicastat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis APL-1401, Placebo - Ulcerative Colitis | Phase 1 | Unknown | Jiangsu Yahong Meditech Co., Ltd aka Asieris | 36 | 2023-01-26 | 2023-09-06 |
| A Multi-Center Trial of Nepicastat for Cocaine Dependence Nepicastat, Placebo - Cocaine Dependence | Phase 2 | Completed | National Institute on Drug Abuse (NIDA) | 179 | 2013-04-01 | 2017-05-18 |
| Nepicastat for Posttraumatic Stress Disorder (PTSD) in OIF/OEF Veterans Nepicastat, Placebo - Posttraumatic Stress Disorder | Phase 2 | Completed | Tuscaloosa Research & Education Advancement Corporation | 100 | 2009-07-01 | 2017-10-13 |
| Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD) SYN117 (nepicastat), Placebo comparator - Post Traumatic Stress Disorder (PTSD) | Phase 2 | Withdrawn | Michael E. DeBakey VA Medical Center | 2008-06-01 | 2019-08-21 |
Stress Disorders, Post-Traumatic (2) · Cocaine-Related Disorders (1) · Colitis, Ulcerative (1)
Jiangsu Yahong Meditech Co., Ltd aka Asieris (1) · Michael E. DeBakey VA Medical Center (1) · National Institute on Drug Abuse (NIDA) (1) · Tuscaloosa Research & Education Advancement Corporation (1)
United States (4)
Carlos Berry, M.D. (1) · David P. Graham, MD (1) · Lori Davis, MD (1) · Mark Hamner, MD (1) · Qiuyue QU (1) · Thomas Kosten, MD (1)